Commonground
Senior Moderator
Influenza A/H1N1 vaccine will be injected for 5% of the population
Thursday, October 29, 2009
Ministry of Health said there is not currently detect gene variations, including cases of severe complications. Cases of death from influenza A/H1N1 were subject to high risk (pregnant women, persons with chronic disease, children under two years) to the treatment late, usually after three to 10 days the onset of symptoms.
He said the number of Russian cases increased very rapidly in the community, if the system does not meet the treatment, no treatment in time of death will increase.
Prof. Nguyen Hong Hanh - Vice Director of the Institute of Hygiene and Epidemiology for Surgeons in the hospital last week received 100 samples products. Test results showed that 93 per cent up samples influenza A/H1N1 virus infection products.
To address this problem, TS. Trinh Quan Huan - Deputy Minister of Health said that in the winter when the flu season, most patients with influenza A/H1N1 virus infection is therefore the basis of medical need of treatment for patients with influenza immediately follow treatment guidelines without influenza A/H1N1 tests.
According to Dr Nguyen Van Kinh - The Director of Institute of Infectious Diseases and Tropical countries is 80 percent of patients with influenza A/H1N1 infection without treatment at the hospital that can receive the drug Tamiflu and treatment in home to avoid overloading the hospital.
But in accordance with the health sector should be granted a new hospital medicine, this should cause overload in many hospitals in the area of Hanoi. Dear so he recommended antiviral drug for the communes and wards for patients receiving the drug there.
However, Deputy Minister Trinh Quan Huan worried greatest risk today is the drug Tamiflu-resistant virus and actually have 13-14 informed about the status of drug resistance in patients with influenza. In Vietnam also appeared the phenomenon of drug-resistant, so if no one has massively drug control is surely virus H1N1se Tamiflu resistance. When it will not "weapons" to treat H1N1 virus again.
Deputy Head for the Ministry of Health is considering this issue and requested the Subcommittee meeting and make treatment recommendations to resolve the issue of treatment towards the most optimal.
Mr. Nguyen Van Thanh - Deputy Director of Department of Pharmaceutical Management Agency said the document sent to the company's vaccine business proposal registrar circulating influenza A/H1N1 vaccine in Vietnam for a week now. However, until now the company does not have to register or file a formal answer. Therefore plan for vaccine inoculation object priority can be back.
Dr. Head for the number of H1N1 vaccine supply company is organizing the World Health accept no more so very limited amount of vaccine. Vietnam is expected to influenza A/H1N1 vaccine injection for one to five percent of the population, concentrated mainly on pregnant women, children, the chronically sick, the elderly and treating physician directly.
http://translate.googleusercontent....le.com&usg=ALkJrhifdmoUYLhZwKUuP4w0A71uInmOWw
Thursday, October 29, 2009
Ministry of Health said there is not currently detect gene variations, including cases of severe complications. Cases of death from influenza A/H1N1 were subject to high risk (pregnant women, persons with chronic disease, children under two years) to the treatment late, usually after three to 10 days the onset of symptoms.
He said the number of Russian cases increased very rapidly in the community, if the system does not meet the treatment, no treatment in time of death will increase.
Prof. Nguyen Hong Hanh - Vice Director of the Institute of Hygiene and Epidemiology for Surgeons in the hospital last week received 100 samples products. Test results showed that 93 per cent up samples influenza A/H1N1 virus infection products.
To address this problem, TS. Trinh Quan Huan - Deputy Minister of Health said that in the winter when the flu season, most patients with influenza A/H1N1 virus infection is therefore the basis of medical need of treatment for patients with influenza immediately follow treatment guidelines without influenza A/H1N1 tests.
According to Dr Nguyen Van Kinh - The Director of Institute of Infectious Diseases and Tropical countries is 80 percent of patients with influenza A/H1N1 infection without treatment at the hospital that can receive the drug Tamiflu and treatment in home to avoid overloading the hospital.
But in accordance with the health sector should be granted a new hospital medicine, this should cause overload in many hospitals in the area of Hanoi. Dear so he recommended antiviral drug for the communes and wards for patients receiving the drug there.
However, Deputy Minister Trinh Quan Huan worried greatest risk today is the drug Tamiflu-resistant virus and actually have 13-14 informed about the status of drug resistance in patients with influenza. In Vietnam also appeared the phenomenon of drug-resistant, so if no one has massively drug control is surely virus H1N1se Tamiflu resistance. When it will not "weapons" to treat H1N1 virus again.
Deputy Head for the Ministry of Health is considering this issue and requested the Subcommittee meeting and make treatment recommendations to resolve the issue of treatment towards the most optimal.
Mr. Nguyen Van Thanh - Deputy Director of Department of Pharmaceutical Management Agency said the document sent to the company's vaccine business proposal registrar circulating influenza A/H1N1 vaccine in Vietnam for a week now. However, until now the company does not have to register or file a formal answer. Therefore plan for vaccine inoculation object priority can be back.
Dr. Head for the number of H1N1 vaccine supply company is organizing the World Health accept no more so very limited amount of vaccine. Vietnam is expected to influenza A/H1N1 vaccine injection for one to five percent of the population, concentrated mainly on pregnant women, children, the chronically sick, the elderly and treating physician directly.
http://translate.googleusercontent....le.com&usg=ALkJrhifdmoUYLhZwKUuP4w0A71uInmOWw